These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9643348

  • 41. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
    Yang DS, Smith JD, Zhou Z, Gandy SE, Martins RN.
    J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
    [Abstract] [Full Text] [Related]

  • 42. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.
    van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, de Bruijn I, van Vlijmen B, van der Boom H, Havekes LM, Frants RR.
    J Biol Chem; 1993 May 15; 268(14):10540-5. PubMed ID: 7683682
    [Abstract] [Full Text] [Related]

  • 43. Replacement of helix 1' enhances the lipid binding activity of apoE3 N-terminal domain.
    Redmond KA, Murphy C, Narayanaswami V, Kiss RS, Hauser P, Guigard E, Kay CM, Ryan RO.
    FEBS J; 2006 Feb 15; 273(3):558-67. PubMed ID: 16420479
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The redox status of cysteine thiol residues of apolipoprotein E impacts on its lipid interactions.
    Yamauchi K, Kawakami Y.
    Biol Chem; 2020 Apr 28; 401(5):617-627. PubMed ID: 31913846
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Human apolipoprotein E7:lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins.
    Dong J, Balestra ME, Newhouse YM, Weisgraber KH.
    J Lipid Res; 2000 Nov 28; 41(11):1783-9. PubMed ID: 11060347
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability?
    Weers PM, Narayanaswami V, Choy N, Luty R, Hicks L, Kay CM, Ryan RO.
    Biophys Chem; 2003 Nov 28; 100(1-3):481-92. PubMed ID: 12646385
    [Abstract] [Full Text] [Related]

  • 51. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization.
    Westerlund JA, Weisgraber KH.
    J Biol Chem; 1993 Jul 25; 268(21):15745-50. PubMed ID: 8340399
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia.
    Georgiadou D, Chroni A, Vezeridis A, Zannis VI, Stratikos E.
    PLoS One; 2011 Jul 25; 6(11):e27037. PubMed ID: 22069485
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
    Innerarity TL, Friedlander EJ, Rall SC, Weisgraber KH, Mahley RW.
    J Biol Chem; 1983 Oct 25; 258(20):12341-7. PubMed ID: 6313652
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.